Trade Secret vs Patent

A patent is a government-granted exclusive right to prevent others from making, using, selling, or importing a patented invention for 20 years, in exchange for full public disclosure of the invention. A patent protects against EVERYONE — including competitors who independently invented the same thing without knowing about the patent. After 20 years, the invention enters the public domain. A trade secret is any information that derives economic value from not being generally known, and that is subject to reasonable measures to maintain its secrecy. A trade secret protects against misappropriation (theft or breach of confidence) but provides NO protection against independent invention or reverse engineering. A competitor who discovers the same information independently or reverse-engineers it from a product is free to use it — you have no claim against them. Key differences: (1) Duration: patents expire at 20 years; trade secrets can last indefinitely; (2) Disclosure: patents require full public disclosure; trade secrets require confidentiality; (3) Independent invention: patents block even independent inventors; trade secrets do not; (4) Reverse engineering: patents block reverse engineering; trade secrets do not; (5) Cost: patents cost $10,000–$50,000+ to obtain; trade secrets cost the expense of maintaining secrecy.

Yes — patents and trade secrets can protect different aspects of the same overall technology. You CANNOT keep the specific claimed invention itself as both a patent (which requires disclosure) and a trade secret (which requires secrecy) — once you patent something, it's public. But you can patent one aspect while keeping a different aspect as a trade secret. Common combinations: (1) Patent the product/composition (what the product is and does), keep the manufacturing process as a trade secret — a competitor can't make the product anyway (patent blocks them), and if they find a way around the patent, they still don't have the efficient process; (2) Patent the broad invention, keep specific optimizations as trade secrets — the patent covers the field, the trade secrets cover the details; (3) File a patent on the core algorithm, keep the training data or model weights as trade secrets (common in AI/ML); (4) Patent the system architecture, keep integration details and internal APIs as trade secrets. The Supreme Court confirmed in Kewanee Oil Co. v. Bicron Corp. (1974) that federal patent law does not preempt state trade secret law — companies can choose between, or combine, both systems of protection.

Under both the Defend Trade Secrets Act (DTSA) and the Uniform Trade Secrets Act (UTSA), trade secret protection requires that the owner take 'reasonable measures under the circumstances' to maintain secrecy. There is no single prescribed set of measures — courts evaluate the totality of circumstances. What constitutes reasonable measures: (1) Non-Disclosure Agreements (NDAs): require employees, contractors, business partners, and potential licensees to sign NDAs before accessing the secret. NDAs must identify the specific categories of protected information, specify duration (often 'for as long as the information remains confidential'), and be signed before access. (2) Employee confidentiality agreements: at-will employment + NDA + acknowledgment of confidentiality obligations as part of the onboarding process; exit interviews reminding departing employees of their ongoing obligations. (3) Access restriction: limit knowledge of the secret to those who need it (need-to-know basis); maintain separate access controls for especially sensitive information; use compartmentalization for the most critical trade secrets (no single employee knows the whole formula). (4) Physical security: locked facilities, restricted access areas, security cameras for areas where the secret is used or stored. (5) IT security: password protection, encryption, access logs, monitoring for data exfiltration. (6) Marking documents as 'Confidential' and 'Trade Secret': label all documents containing trade secrets to put recipients on notice. (7) Licensing: when sharing trade secrets with partners, use written license agreements with explicit confidentiality obligations and audit rights. What does NOT constitute reasonable measures: (a) oral confidentiality agreements (unenforceable or unverifiable); (b) no restrictions at all on access; (c) sharing the secret publicly without protection; (d) disclosing to investors without an NDA. Failure to take reasonable measures can result in loss of trade secret status — a competitor who receives the information is not bound by secrecy obligations if the owner didn't create them.

The Defend Trade Secrets Act (DTSA), enacted May 11, 2016 (18 U.S.C. §§ 1836–1839), created a federal civil cause of action for trade secret misappropriation for the first time. Before DTSA, trade secret claims were limited to state law (mostly under the Uniform Trade Secrets Act adopted by most states). DTSA provides: (1) Federal court jurisdiction: trade secret cases can now be filed in federal district courts without relying on diversity jurisdiction or tacking onto other federal claims; (2) Nationwide reach: better for cases involving misappropriation across state lines, international theft, or cases where state law is unclear; (3) Expanded remedies including injunctive relief that can be tailored to conditions of employment (unlike some state laws); (4) Ex parte seizure order (emergency provision, 18 U.S.C. § 1836(b)(2)): in extraordinary circumstances, a federal court can issue an ex parte order seizing property containing the misappropriated trade secret — without notice to the defendant — to prevent propagation or dissemination. This is a drastic remedy and courts use it sparingly; (5) Damages: compensatory damages for actual loss, unjust enrichment, AND at the court's discretion exemplary damages up to 2× the compensatory damages if willful and malicious misappropriation is shown; attorney fees for willful misappropriation; (6) Whistleblower immunity: employees who disclose trade secrets to government authorities in connection with reporting a violation of law are immune from DTSA liability; employers must include this immunity notice in any NDA or confidentiality agreement — failure to include the notice means the employer cannot claim punitive damages or attorney fees in a DTSA suit against that employee. Key cases: Waymo v. Uber (N.D. Cal. 2018 settlement — $245 million in Uber equity resolved trade secret claims involving self-driving car technology; first major DTSA case in practice). DTSA supplements, not replaces, state trade secret law — claims can be brought under both.

When a former employee misappropriates a trade secret — by taking confidential documents, downloading proprietary data, memorizing formulas, or using the secret at a new employer — the original employer has legal remedies under the DTSA and applicable state law. The remedies: (1) Injunction: a court can order the former employee and the new employer to stop using the trade secret; this is available even if the misappropriation has already occurred; (2) Damages: the employer can recover actual losses caused by the misappropriation (lost profits, lost licensing opportunities, diminished business value), unjust enrichment (profits the employee/new employer made from using the secret), and up to 2× exemplary damages for willful misappropriation under DTSA; (3) Criminal liability: under the federal Economic Espionage Act (EEA, 18 U.S.C. §§ 1831-1839), theft of trade secrets is a federal crime — individuals face up to 10 years imprisonment, and organizations face fines up to $5 million or 3× the value of the stolen trade secret. The 'inevitable disclosure' doctrine: in some states (Illinois, Minnesota, others), an employer can seek an injunction to prevent a former employee from working for a competitor even without proof of actual disclosure, if the employee's new role would 'inevitably' require using or disclosing the trade secret. However, this doctrine is not accepted in all states (California rejects it). Practical advice for employers: (1) Always have NDA + trade secret acknowledgment signed at hire; (2) Conduct exit interviews and remind departing employees of their confidentiality obligations; (3) Send a written reminder of obligations to the employee and the new employer (a 'non-solicitation letter' or 'trade secret notice letter') immediately after learning of the departure — this establishes notice and may deter misappropriation; (4) Conduct a forensic investigation of the employee's computer and email before or after departure to document any exfiltration; (5) Act quickly — delay weakens injunctive relief requests.